Improved Prognosis of Infection With Mycobacterium Genavense in Immune-Compromized HIV Patients After Introduction of Combined Antiretroviral Therapy

J Acquir Immune Defic Syndr. 2021 Jan 1;86(1):e9-e12. doi: 10.1097/QAI.0000000000002513.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Retroviral Agents / therapeutic use*
  • HIV Infections / drug therapy*
  • HIV Infections / immunology*
  • Humans
  • Male
  • Mycobacterium
  • Mycobacterium Infections / immunology*
  • Mycobacterium Infections / physiopathology
  • Prognosis

Substances

  • Anti-Retroviral Agents

Supplementary concepts

  • Mycobacterium genavense